ABVIDA TRIO 1000 (Dapagliflozin (10mg) + Metformin (1000mg) + Vildagliptin (100mg))

ABVIDA TRIO 1000 is a combination medication designed to help manage high blood sugar levels in adults with type 2 diabetes. It works by addressing several aspects of diabetes control, providing support to individuals aiming to maintain their blood sugar within a target range. This medication is particularly beneficial for those who may require multiple approaches to achieve effective management of their condition.

The formulation includes three active ingredients: Dapagliflozin, Metformin, and Vildagliptin. Dapagliflozin helps the kidneys remove excess glucose from the bloodstream, while Metformin improves the body’s sensitivity to insulin and reduces sugar production in the liver. Vildagliptin works by increasing insulin secretion in response to meals and lowering glucagon levels, which helps to further regulate blood sugar.

For optimal effectiveness, it is important to use ABVIDA TRIO 1000 consistently as directed by a healthcare provider. Store the medication in a cool, dry place away from moisture and direct sunlight. It is also advisable to monitor blood sugar levels regularly and maintain a healthy lifestyle, including a balanced diet and regular exercise.

Some common, mild side effects may include gastrointestinal discomfort, such as nausea or diarrhea, as well as headache or dizziness. These effects are usually temporary and may lessen as the body adjusts to the medication.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.